Business Wire

PIMCO Selects Algomi ALFA to Source Liquidity in Fragmented Bond Market

Share

Algomi, which provides data aggregation technology for the optimization of fixed income liquidity, today announced that PIMCO, one of the world’s premiere fixed income investment managers, is using Algomi ALFA inside the firm’s trading and data infrastructure.

With Algomi ALFA, PIMCO now has access to bond price information from all major electronic venues, messaging platforms and dealer inventory feeds combined into a single consolidated landscape. Algomi ALFA simplifies fixed income trading and allows for investors to tap into today’s fractured bond markets.

PIMCO will intergrate Algomi ALFA into its 100 strong bond trading desk-based in California along with its domestic and international offices. Unlike the equity markets, fixed income inventory includes corporate investment grade, high yield, emerging markets, municipal, structured credit and government debt. This is scattered across many electronic venues globally along with the thousands of securities typically traded through voice trading.

Dirk Manelski, CTO of PIMCO says: “Fixed income asset managers need to quickly integrate and analyze data to stay competitive and Algomi ALFA’s strategic fixed income technology will capture, normalize and create a centralized repository of information that will help PIMCO optimize efficiencies and cut costs.”

“We are very excited to partner with Algomi. It fits well with our efforts of identifying and using newer technologies and solutions to help deliver stronger investment returns for our clients. Algomi’s systems will help access data and market information from a wide array of sources in a unified and aggregated manner which will help us further enhance efficiency in the trading and risk management,” said Mohit Mittal, Managing Director and Portfolio Manager.

Scott Eaton, CEO, Algomi comments: “Innovative buy-side managers know that organizing their available information and systems into actionable insights is essential to being successful in today’s market. I am proud that one of the world’s leading asset managers has validated our model by using Algomi ALFA for organizing fixed income trading.”

Richard Colucci, Head of Algomi Americas said “Companies are beginning to make technology investments that can truly exploit data science and automation to grow and evolve with the market. These efforts are fueled by a robust and normalized dataset. Algomi ALFA is AWS cloud-enabled, compatible with API integration and built on top of OpenFin open-source technology, giving our customers the flexibility they need for tomorrow.”

Notes to Editors

About Algomi

Algomi is a software company that provides technology to financial market participants to improve their workflow and liquidity by data aggregation, pre-trade information analysis, and execution facilitation. We are a market neutral system provider, using our expertise in technological facilitation to improve liquidity and efficiency in the market.

Founded in 2012, Algomi is headquartered in London with offices in New York and Hong Kong. Algomi’s strength and stability comes through investment from AllianceBernstein, Euroclear, Euronext, and S&P Global.

About PIMCO

PIMCO is one of the world’s premier fixed income investment managers.

With our launch in 1971 in Newport Beach, California, PIMCO introduced investors to a total return approach to fixed income investing. In the 45+ years since, we have continued to bring innovation and expertise to our partnership with clients seeking the best investment solutions. Today we have offices across the globe and 2,600 professionals united by a single purpose: creating opportunities for investors in every environment.

Contact information

PRESS
ALGOMI
Mariah Measey
Cognito
+1 646 395 6335
algomi@cognitomedia.com

PIMCO
Agnes Crane
U.S. Corporate Communications – New York
+1 212 597 1054
agnes.crane@pimco.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

New Data from the Phase 3 HELP Study Open-Label Extension Evaluate the Long-Term Safety and Efficacy of TAKHZYRO ® (lanadelumab) in Reducing Hereditary Angioedema Attacks6.6.2020 09:05:00 CESTPress release

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced findings from two new interim analyses of data from the Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-label Extension (OLE). The analyses suggest that TAKHZYRO® (lanadelumab) is well-tolerated and can prevent hereditary angioedema (HAE) attacks over an extended treatment period, with sustained and consistent reduction in monthly attack rate across a range of different patient subgroups. The data are being presented at the 2020 European Academy of Allergy and Clinical Immunology (EAACI) Digital Congress. The original Phase 3 HELP Study was conducted in 125 patients aged 12 years and older over 26 weeks, making it the largest randomised, controlled prevention study in HAE, with the longest active treatment duration, to date.1 The HELP Study OLE was designed to evaluate the long-term safety (primary endpoint) and efficacy of TAKHZYRO for up to 2.5 years and was completed in Novemb

FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump5.6.2020 13:00:00 CESTPress release

Abiomed (NASDAQ: ABMD) announces the United States Food and Drug Administration (FDA) has approved the company's investigational device exemption application to start an early feasibility study with a first-in-human trial of the 9 French (Fr) Impella ECP™ heart pump. Impella ECP, which stands for expandable cardiac power, will be studied in high-risk percutaneous coronary intervention (PCI) patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200605005049/en/ FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump Impella ECP is the world’s smallest heart pump. It achieves peak flows greater than 3.5 L/min and is delivered though a slender-profile sheath. It is un-sheathed in the descending aorta and expands to approximately 18 Fr. Using a specially designed pigtail, it crosses the aortic valve without a wire, and pumps from inside the ventricle. When the procedure is complete, the pump is

Next generation of DataOps, provided by Datalytyx, now available through Snowflake Partner Connect Program!5.6.2020 11:10:00 CESTPress release

Datalytyx today announced an expanded partnership with Snowflake, the Cloud Data Platform, that enables the next generation Datalytyx DataOps for Snowflake platform to be deployed for a 2 week trial on Snowflake. Customers can orchestrate the ingestion of data from many on-premise and cloud platforms via 3rd party data tools, model data easily, automatically test those models as part of their pipelines, launch AI/ML models and enable the consumption of data to deliver immediate stakeholder value. As a great example, in the midst of the Coronavirus pandemic, BOC, the UK market-leading gas supply company for delivery of healthcare oxygen, has faced unprecedented demand, from equipping Nightingale hospitals to delivering O2 cylinders in homes. Datalytyx have deployed their DataOps for Snowflake platform to help BOC manage their cylinder stock and logistics data, for all types of gases, to increase production efficiency and provide best-in-class customer service. “Datalytyx said they could

Pegasus Development AG: Green Light for Multiple Production Sites Worldwide5.6.2020 09:27:00 CESTPress release

Announcement: Expansion of the Pegastril-Nuevo production facility Under the leadership of board member Roberto Spano, the management of Pegasus Development AG has decided to further expand Pegastril-Nuevo production facilities. New production facilities will be set up at several locations across the world and the site in Turkey is being expanded. These investments will also create new jobs. The takeover and expansion of the following production facilities are planned in all 20 countries of Latin America, as well as France, Spain, Portugal, Greece, Cyprus, Nigeria, Ethiopia, Uganda, Tanzania, Mozambique, Angola, Mauritius, Guinea-Bissau, Cape Verde, São Tome, and Mongolia. The demand for disinfectants has skyrocketed as a result of the coronavirus. Especially high revenues are expected from products which are based on vegetable surfactants and are alcohol-free, such as Nuevo. This was the decisive factor in the management's decision to further expand the quantity and range of Nuevo pro

In COVID-19, Pudu Robotics Provides Non-contact Delivery Service in Hundreds of Hospitals Worldwide5.6.2020 09:00:00 CESTPress release

During COVID-19, hundreds of Pudu Robotics’ robot Pudubot is offering delivery service in hospitals worldwide. This non-contact delivery service by Pudubot helps avoid the spread of virus. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200605005095/en/ (Photo: Business Wire) After the outbreak of COVID-19, the pandemic with the characteristic of human-to-human transmission, a large number of hospitals and restaurants are seeking help from Pudu Robotics out of an urgent need for non-contact delivery. Pudu Robotics responded positively by devoting robots to several hospitals in Seoul, South Korea, Beijing, China, Wuhan, China and so on. Because Pudu Robotics’ robots are fully automatic, they can achieve the delivery process all by themselves, which reduces contact between people and effectively prevents the spread of the virus. Pudubot is equipped with multi-sensor and positioning and navigation technology. With large-capacity

IDEMIA and BBVA Partner to Launch Spain’s First Payment Card Made of Recycled PVC5.6.2020 09:00:00 CESTPress release

IDEMIA, the global leader in Augmented Identity, is supplying the very first cards made out of recycled plastics in Spain to BBVA. The bank will first distribute the cards to their Spanish customers with a BBVA Youth Account in June 2020. This new payment card is a strong commitment from BBVA to contributing to the United Nations Sustainable Development Goals for the fight against climate change. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200605005037/en/ (Graphic: Business Wire) Each year, approximately 6 billion plastic payment cards are produced according to the 2018 Nilson Report1. In the context of the United Nations Sustainable Development Goals and the Paris Agreement, IDEMIA’s cutting-edge technology has been selected by BBVA, one of the largest banks in Spain, to migrate part of its existing first-use PVC cards to innovative recycled PVC cards. By the end of the year BBVA will enable more than half a million Spa